Based on current information, several online telehealth providers offer Ozempic prescriptions and assist with the prior authorization (PA) process with insurance companies. However, it is important to note that Ozempic is FDA-approved only for Type 2 Diabetes, not for weight loss, which significantly impacts insurance coverage eligibility. Here are the key online providers that handle prior authorization: PlushCare PA Handling: PlushCare states that their physicians and care team will reach out to your insurer on your behalf to handle the prior authorization request. Note: They emphasize that a Type 2 Diabetes diagnosis is required for insurance approval. The process can take several business days. Cost: They offer virtual visits with insurance (often $30 or less for in-network) or cash pay ($129 for initial visits). Ro (Ro Body) PA Handling: Ro offers an insurance concierge service. Their concierge "fights for coverage," submits all paperwork, and works with the insurance provider to determine coverage for GLP-1 medications. Note: Ro explicitly states Ozempic is not FDA-approved for weight loss. They may prescribe it off-label. Their insurance concierge is separate from the Ro Body membership fee (which is cash-only). Limitation: They currently cannot coordinate coverage for GLP-1s for government insurance plans (e.g., Medicare), though they may assist with private plans. Plastic & Ro (General Telehealth) Many other telehealth platforms (like Ro, PlushCare, Klarity, and HelloKlarity) can* initiate the prescription, but their ability to secure insurance coverage depends entirely on the patient meeting the PA criteria (Type 2 Diabetes). Klarity Health / HelloKlarity: These platforms often focus on weight loss. While they can evaluate weight loss needs, they frequently inform patients that insurance coverage for weight loss is unlikely without a diabetes diagnosis, and they may not have a dedicated "concierge" team to fight for PA in the same way Ro does. CoverMyMeds & Spry (Technology Partners, Not Providers) It is worth noting that many providers use third-party platforms like CoverMyMeds or Spry to automate and submit prior authorization requests electronically. These tools streamline the process for providers but are not the direct patient-facing "providers" themselves. Critical Considerations for Prior Authorization: Diagnosis Requirement: Almost all insurance companies will deny prior authorization for Ozempic if the patient only has a weight loss diagnosis. A Type 2 Diabetes diagnosis is typically mandatory for coverage. Weight Loss vs. Diabetes: If you are seeking Ozempic strictly for weight loss, you may face auto-denials from insurance regardless of the provider. You may need to pay the full cash price (approx. $949/month) or use a savings offer (e.g., from NovoCare). Appeals: If a PA is denied, providers like Ro and PlushCare can assist in filing an appeal or initiating a peer-to-peer review with the insurer. Recommendation: If you have Type 2 Diabetes, PlushCare and Ro are the most robust options for handling PA actively. If you are seeking Ozempic only for weight loss, be prepared that most insurance plans will deny coverage regardless of the provider, and you should verify cash prices or savings programs beforehand.
Mentioned in position 4 of 7
Read full answer with sources →